Sugemalimab (Anti-B7-H1 / PD-L1 / CD274)
A2783
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameSugemalimab (Anti-B7-H1 / PD-L1 / CD274)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionSugemalimab (Anti-B7-H1 / PD-L1 / CD274) is a fully human anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small-cell lung cancer research. MW: 143.36 kD.
- Storage Instruction-20°C
- UNSPSC12352203